Lisinopril (Carace - MSD, Zestril - ICI) has joined captopril and enalapril1 as the third inhibitor of angiotensin-converting enzyme (ACE), for use in hypertension and heart failure. Advantages claimed for lisinopril are that it is not a pro-drug, its once daily dosage and its ability “to retain that zest for life” during antihypertensive therapy.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.